Lactate dehydrogenase linked to incident diabetic retinopathy among diabetics

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-09-29 05:15 GMT   |   Update On 2023-09-29 10:42 GMT

China: A recent study evaluated the level of relationship between lactate dehydrogenase (LDH) and the occurrence of diabetic retinopathy (DR) in patients with diabetes mellitus (DM). The researchers revealed that LDH concentrations are connected with an increased prevalence of DR in diabetes patients.The study, published in the Journal of Diabetes, highlights that patients with LDH > 134...

Login or Register to read the full article

China: A recent study evaluated the level of relationship between lactate dehydrogenase (LDH) and the occurrence of diabetic retinopathy (DR) in patients with diabetes mellitus (DM). The researchers revealed that LDH concentrations are connected with an increased prevalence of DR in diabetes patients.

The study, published in the Journal of Diabetes, highlights that patients with LDH > 134 U/L are distinguishably related to diabetes mellitus complicated by diabetic retinopathy. The researchers note that DR is more common in diabetic patients with coronary heart disease (CHD).

Lactate dehydrogenase is a glycolytic enzyme that significantly impacts metabolic oxidative stress (OS). There is a positive correlation between the cumulative amount of LDH and the number of damaged cells. Previous studies have shown that unstable hyperglycemia can stimulate the action of protein kinase C and trigger an OS response. Lack of oxygen and elevated glucose levels have been observed to raise LDL levels in retina cells.

Oxidative stress is critical in the pathophysiology of diabetic retinopathy. The overabundance of reactive oxygen species holds the potential to cause tissue damage in the surrounding area of retinal blood vessels, ultimately leading to DR development.

Gangyi Yang, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China, and colleagues therefore aimed to evaluate the level of relationship between lactate dehydrogenase and the occurrence of diabetic retinopathy in adults with diabetes.

For this purpose, the researchers analyzed five sectional data cycles acquired from the National Health and Nutrition Examination Survey from 2009 to 2018. The study involved the selection of diabetes mellitus samples from a complex multistage probability sample. Subsequently, these samples were classified into two distinct groups, the No DR (NDR) and DR groups.

The researchers comprehensively investigated the social and biological risk factors associated with DR. The biological factors examined in the investigation included blood routine, blood pressure, blood glucose, haemoglobin A1c, and comorbidities. The social dimensions encompass sex and education.

The study led to the following findings:

  • After considering all factors, multivariate regression models indicated a significant relationship between DR and increased LDH (adjusted odds ratio = 1.007).
  • The subgroup analysis revealed that the effect size of LDH on the existence of DR in the subgroups remained consistent.
  • A statistically significant relationship was identified between elevated LDH levels > 134 U/L and a raised risk of DR in people with DM.

"We discovered that an increased LDH level was connected to an elevated DR incidence," the researchers wrote. "Our research found that when LDH is > 134 U/L, LDH and DR are positively correlated."

They added, "In our subsequent research, we plan to conduct a cohort study to determine the potential of LDH as a predictive factor for DR. At the same time, diabetic patients with CHD should be advised to strengthen DR screening for disability prevention."

Reference:

Yang, P., Xu, W., Liu, L., & Yang, G. Association of lactate dehydrogenase and diabetic retinopathy in US adults with diabetes mellitus. Journal of Diabetes. https://doi.org/10.1111/1753-0407.13476


Tags:    
Article Source : Journal of Diabetes

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News